AstraZeneca has announced the results from its long-awaited US-based clinical trial, saying that its COVID-19 vaccine is safe and provides strong protection against symptomatic infection.
AstraZeneca has announced the results from its long-awaited US-based clinical trial, saying that its COVID-19 vaccine is safe and provides strong protection against symptomatic infection.
While the drug maker AstraZeneca has revised its analysis of a large clinical trial involving its new COVID-19 vaccine, WBZ-TV's..
Drugmaker AstraZeneca announced some promising results from their phase 3 covid vaccine trial reporting their vaccine was 79%..